Cartesian Therapeutics Inc stock is traded at $6.88, with a volume of 134,093. It is down -0.15% in the last 24 hours and down -1.57% over the past month. Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Previous Close:
$6.89
Open:
$6.95
24h Volume:
134,093
Relative Volume:
1.01
Market Cap:
$209.86M
Revenue:
$1.78M
Net Income/Loss:
-$151.77M
P/E Ratio:
-
EPS:
-$5.80
Net Cash Flow:
-$77.37M
1W Performance:
+1.47%
1M Performance:
-1.57%
6M Performance:
-20.92%
1Y Performance:
-9.23%
1-Day Range:
$6.70$7.09
1-Week Range:
$6.70$7.90
52-Week Range:
$5.60$11.00
Cartesian Therapeutics Inc Stock (RNAC) Company Profile
Name
Cartesian Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
301-348-8698Address
7495 NEW HORIZON WAY, FREDERICK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS